No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WST240517C370000
- 1.65
- -2.32-58.44%
15min DelayClose May 9 16:00 ET
1.65High1.65Low
1.65Open3.97Pre Close1 Volume617 Open Interest370.00Strike Price165.00Turnover21.89%IV2.03%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry1.65Time Value100Contract SizeAmericanOptions Type0.3743Delta0.0321Gamma121.86Leverage Ratio-0.3089Theta0.0291Rho45.62Eff Leverage0.2042Vega
Intraday
- 5D
- 1D
News
West Pharmaceutical Services(WST.US) Officer Sells US$24.2 Million in Common Stock
$West Pharmaceutical Services(WST.US)$ Officer Green Eric Mark sold 66,000 shares of common stock on May 7, 2024 at an average price of $366.6523 for a total value of $24.2 million.Source: Announcemen
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing
Eric Mark Green, Director, President, CEO and Board Chair, on May 07, 2024, sold 66,000 shares in West Pharmaceutical Services (WST) for $24,199,050. Following the Form 4 filing with the SEC, Green ha
Form 144 | West Pharmaceutical Services(WST.US) Officer Proposes to Sell 24.3 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 7, $West Pharmaceutical Services(WST.US)$ Officer Green Eric Mark intends to sell 66,000 shares of its common stock on May 7, with a total market value of approximately $24
Declining Stock and Solid Fundamentals: Is The Market Wrong About West Pharmaceutical Services, Inc. (NYSE:WST)?
It is hard to get excited after looking at West Pharmaceutical Services' (NYSE:WST) recent performance, when its stock has declined 8.2% over the past three months. However, a closer look at its sou
West Pharmaceutical Services, Inc. (NYSE:WST) Q1 2024 Earnings Call Transcript
West to Participate in Upcoming Investor Conference
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
Comments
RECAP
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
U.S. equity indexes rose after Thursday, with the $Nasdaq Composite Index(.IXIC.US$ lagging the pack, as investors weighed retail sales and jobless claims ahead of more inflation data this week.
The $S&P 500 Index(.SPX.US$ rose 0.58% to 5,029, a new closing high with the $Dow Jones Industrial Average(.DJI.US$ up 0.91% to 38,664. The $Nasdaq Composite Index(.IXIC.US$ was moderately higher at 15,906, af...
41
5
Analysts worry about the company's shifting tone and the enduring effect of clients' inventory management on West's finances. Doubts also arise about the company's demand visibility and if current trends suggest a fundamental issue in West's base business.
Jefferies analyst David Windley sees FDA approvals of GLP-1s for obesity treatment as a huge opportunity for the manufacturing supply chain. He also notes high rivalry in the injectable fill/finish market. Windley upgraded West Pharmaceutical to Buy, raising its price target by 66% to $536, citing its global footprint and capacity to meet growing GLP-1s demand.
The market sentiment around West Pharmaceutical Services hasn't changed much over the past five years, with the share price seemingly reacting to the EPS. The recent improvement in TSR could indicate that the business is getting better with time.
1
The 4- and 5-star rated Dividend Aristocrats for 2024 include Abbott Laboratories, AbbVie Inc., Air Products & Chemicals, and others such as Coca-Cola Co., McDonald's Corp., Walmart Inc., and West Pharmaceuticals.
1
Read more
Qulynnitha Bowman : How much money do i need to invest in stocks
102556055 : $Futu Holdings Ltd (FUTU.US)$
Cypher : “$Microsoft(MSFT.US)$'s OpenAi released a short 60-minute video.”
The video is 60 seconds, not minutes. The writing quality on this platform has really been down lately. I’ve caught way too many errors.
bellalita : good news
Malik ritduan : oo